Chlorinated Lipid Species in Activated Human Neutrophils: Lipid Metabolites of 2-chlorohexadecanal

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2009 Dec 19

PMID 20019386

Citations 32

Authors

Dhanalakshmi S Anbukumar

Laurie P Shornick

Carolyn J Albert

Melissa M Steward

Raphael A Zoeller

William L Neumann

David A Ford

Affiliations

Soon will be listed here.

Abstract

Neutrophils are important in the host response against invading pathogens. One chemical defense mechanism employed by neutrophils involves the production of myeloperoxidase (MPO)-derived HOCl. 2-Chlorohexadecanal (2-ClHDA) is a naturally occurring lipid product of HOCl targeting the vinyl ether bond of plasmalogens. Previous studies have shown that exogenously-added 2-ClHDA is oxidized to 2-chlorohexadecanoic acid (2-ClHA) and reduced to 2-chlorohexadecanol (2-ClHOH) by endothelial cells. These studies show that both 2-ClHA and 2-ClHOH are produced in activated neutrophils in an MPO- and time-dependent manner and are released by neutrophils into media. 2-ClHDA levels peak following 30 min of phorbol 12-myristate-13-acetate stimulation. In contrast, 2-ClHA and 2-ClHOH levels steadily increased over 60 min, suggesting a precursor-product relationship between 2-ClHDA and both 2-ClHA and 2-ClHOH. Additional experiments using wild-type CHO.K1 and CHO.K1 cells deficient in fatty aldehyde dehydrogenase (FALDH), FAA.K1A, demonstrated that 2-ClHDA oxidation to 2-ClHA is dependent on FALDH activity. Furthermore, mice exposed to intranasal Sendai virus displayed lung neutrophil recruitment, as well as elevated 2-ClHA levels in plasma and bronchoalveolar lavage compared with control-treated mice. Taken together, these data demonstrate, for the first time, that metabolites of 2-ClHDA are produced both in vivo as well as in isolated human neutrophils.

Citing Articles

Lipid biology of plasmalogen-derived halolipids: Signature molecules of myeloperoxidase and eosinophil peroxidase activity.

McGuffee R, Hadfield C, Ford D Redox Biochem Chem. 2023; 5-6.

PMID: 38073668 PMC: 10704997. DOI: 10.1016/j.rbc.2023.100011.

Characterization of N-Acetyl Cysteine Adducts with Exogenous and Neutrophil-Derived 2-Chlorofatty Aldehyde.

Shakya S, McGuffee R, Ford D Antioxidants (Basel). 2023; 12(2).

PMID: 36830062 PMC: 9952649. DOI: 10.3390/antiox12020504.

Myeloperoxidase-derived hypochlorous acid targets human airway epithelial plasmalogens liberating protein modifying electrophilic 2-chlorofatty aldehydes.

Shakya S, Pyles K, Albert C, Patel R, McCommis K, Ford D Redox Biol. 2022; 59:102557.

PMID: 36508858 PMC: 9763693. DOI: 10.1016/j.redox.2022.102557.

Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection.

Pike D, McGuffee R, Geerling E, Albert C, Hoft D, Shashaty M Front Cell Dev Biol. 2022; 10:912880.

PMID: 35784479 PMC: 9242022. DOI: 10.3389/fcell.2022.912880.

Endothelial Cell Protein Targeting by Myeloperoxidase-Derived 2-Chlorofatty Aldehyde.

Shakya S, Herr R, Carlson H, Zoeller R, Albert C, Ford D Antioxidants (Basel). 2022; 11(5).

PMID: 35624804 PMC: 9138145. DOI: 10.3390/antiox11050940.

References

BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

Hawley H, Gordon G . The effects of long chain free fatty acids on human neutrophil function and structure. Lab Invest. 1976; 34(2):216-22. View

Rizzo W, Heinz E, Simon M, Craft D . Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome. Biochim Biophys Acta. 2000; 1535(1):1-9. DOI: 10.1016/s0925-4439(00)00077-6. View

Winterbourn C, van den Berg J, ROITMAN E, Kuypers F . Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch Biochem Biophys. 1992; 296(2):547-55. DOI: 10.1016/0003-9861(92)90609-z. View

Suganami T, Nishida J, Ogawa Y . A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005; 25(10):2062-8. DOI: 10.1161/01.ATV.0000183883.72263.13. View

Harrison J, Schultz J . Studies on the chlorinating activity of myeloperoxidase. J Biol Chem. 1976; 251(5):1371-4. View

Curzio M, Di Mauro C, Esterbauer H, DIANZANI M . Chemotactic activity of aldehydes. Structural requirements. Role in inflammatory process. Biomed Pharmacother. 1987; 41(6):304-14. View

Wildsmith K, Albert C, Anbukumar D, Ford D . Metabolism of myeloperoxidase-derived 2-chlorohexadecanal. J Biol Chem. 2006; 281(25):16849-16860. DOI: 10.1074/jbc.M602505200. View

Daugherty A, Dunn J, Rateri D, Heinecke J . Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994; 94(1):437-44. PMC: 296328. DOI: 10.1172/JCI117342. View

10.

Klebanoff S, WALTERSDORPH A, Rosen H . Antimicrobial activity of myeloperoxidase. Methods Enzymol. 1984; 105:399-403. DOI: 10.1016/s0076-6879(84)05055-2. View

11.

Akamatsu H, Niwa Y, Matsunaga K . Effect of palmitic acid on neutrophil functions in vitro. Int J Dermatol. 2001; 40(10):640-3. DOI: 10.1046/j.1365-4362.2001.01292.x. View

12.

Thukkani A, McHowat J, Hsu F, Brennan M, Hazen S, Ford D . Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation. 2003; 108(25):3128-33. DOI: 10.1161/01.CIR.0000104564.01539.6A. View

13.

Albert C, Crowley J, Hsu F, Thukkani A, Ford D . Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal. J Biol Chem. 2001; 276(26):23733-41. DOI: 10.1074/jbc.M101447200. View

14.

Bradley P, Priebat D, Christensen R, ROTHSTEIN G . Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982; 78(3):206-9. DOI: 10.1111/1523-1747.ep12506462. View

15.

Ferrante A, Thong Y . Simultaneous preparation of mononuclear and polymorphonuclear leucocytes from horse blood on Ficoll-Hypaque medium. J Immunol Methods. 1980; 34(4):279-85. DOI: 10.1016/0022-1759(80)90100-3. View

16.

Zigmond S, Hirsch J . Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973; 137(2):387-410. PMC: 2139498. DOI: 10.1084/jem.137.2.387. View

17.

Shornick L, Wells A, Zhang Y, Patel A, Huang G, Takami K . Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J Immunol. 2008; 180(5):3319-28. DOI: 10.4049/jimmunol.180.5.3319. View

18.

Weiss S, Klein R, Slivka A, Wei M . Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest. 1982; 70(3):598-607. PMC: 370261. DOI: 10.1172/jci110652. View

19.

James P, Rizzo W, Lee J, Zoeller R . Isolation and characterization of a Chinese hamster ovary cell line deficient in fatty alcohol:NAD+ oxidoreductase activity. Proc Natl Acad Sci U S A. 1990; 87(16):6102-6. PMC: 54480. DOI: 10.1073/pnas.87.16.6102. View

20.

Rakita R, Michel B, Rosen H . Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry. 1990; 29(4):1075-80. DOI: 10.1021/bi00456a033. View